DiaGenic ASA
1DiaGenic ASA, Østensjoveien 15B, N-0661, Oslo, Norway. praveen.sharma@diagenic.com.
Abstract:
DiaGenic ASA is an innovative Norwegian biotechnology company that seeks to create value for patients, partners and investors by developing new and more patient-friendly diagnostic tests for the early detection of diseases. The company's diagnostic methodology is based on mining disease-specific gene expression signature from easily available clinical samples such as peripheral blood. This patented method has significant potential in the early detection of several important diseases, such as breast cancer and Alzheimer's disease (AD). The company has recently shown that blood-based gene expression tests can be developed for the early detection of both breast cancer and AD. It is expected that DiaGenic will have a prototype ready for its first products by late 2006.
More Related Videos
07:49Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
Published on: July 17, 2019
05:33Author Spotlight: Characterizing Novel Enzymes from Extremophiles and Common Pathogens to Understand DNA Repair and Replication
Published on: July 5, 2024
Related Concept Videos
Transgenic Organisms
Cis-regulatory Sequences
Exon Recombination
Exon shuffling follows “splice frame rules.” Each exon has three reading...
Reporter Genes
Commonly used reporter...
Cis-regulatory Sequences
Genetic Material
